Many PICCs Placed Have Dwell Time of No More Than Five Days

Share this content:
Many PICCs Placed Have Dwell Time of No More Than Five Days
Many PICCs Placed Have Dwell Time of No More Than Five Days

WEDNESDAY, March 7, 2018 (HealthDay News) -- About 25 percent of peripherally inserted central catheters (PICCs) placed have a dwell time of five days or less, and almost 10 percent of patients with a short-term PICC experience a complication, according to a study published in the February issue of the Journal of Hospital Medicine.

David Paje, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues collected data from medical records of adults who received PICCs during hospitalization. Patients were followed until PICC removal, death, or 70 days after insertion. The authors examined factors that were associated with short-term PICCs, with a dwell time of less than or equal to five days.

The researchers found that 25.3 percent of the 15,397 PICCs placed had a dwell time of less than or equal to five days; most of these (95.5 percent) were removed during hospitalization. Variables associated with short-term PICCs versus those placed for more than five days included difficult venous access, multilumen devices, and teaching hospitals (odds ratios, 1.54, 1.53, and 1.25, respectively). Overall, 9.6 percent of those with short-term PICCs experienced a complication, including 2.5 percent and 0.4 percent experiencing venous thromboembolism and central line-associated bloodstream infection events, respectively. Catheter occlusion and tip migration were the most common minor complications (4 and 2.2 percent, respectively).

"As PICC placement, even for brief periods, is associated with complications, efforts targeted at factors underlying such use appear necessary," the authors write.

One author disclosed financial ties to the publishing industry and provided expert witness testimony; several authors disclosed ties to the health insurance industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »